UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 8-K ___________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 ___________________________ G1 THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) ___________________________ Delaware 001-38096 26-3648180 (State or other jurisdiction (Commission (IRS Employer of incorp ...